Endometrial Cancer Market Report- Insights on Growth Trends, Top Players, Types, Applications and Regional Analysis

ReportsnReports added Endometrial Cancer Market Research Report created by Report Consultant, which offers detailed insights, revenue details, and other information regarding the global market, and the various trends, drivers, restraints, opportunities, and market till 2028. Endometrial Cancer Market Report offers detailed information regarding the leading key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions and mergers, and market footprint. Endometrial Cancer Market also provides a comparative analysis of the market dynamics pre and post Covid19 outbreak.

Request for FREE PDF Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4430796

Endometrial cancer is the most common form of uterine cancer, arising from the endometrial lining of the uterus. Endometroid endometrial cancer is highly associated with increased estrogen levels, making it more common among young women, women with higher levels of body fat, and in those taking a form of exogenous estrogen.

In the 8MM, the diagnosed incident cases of endometrial cancer are expected to increase from 120,883 cases in 2020 to 133,690 cases in 2030, at an Annual Growth Rate (AGR) of 1.06%. In the five major European markets (5EU: France, Germany, Italy, Spain, and the UK), the diagnosed incident cases of endometrial cancer are expected to increase from 42,775 cases in 2020 to 47,947 cases in 2030, at an AGR of 1.21%. When examining the AGR by individual market, GlobalData forecasts that all markets will see an increase in the diagnosed incident cases of endometrial cancer during the forecast period. As seen in Figure 2, in 2020, there were 483,737 five-year diagnosed prevalent cases of endometrial cancer in the 8MM, which is expected to increase to 547,783 cases by 2030, at an AGR of 1.32%.

Scope of this Report-
– The Endometrial Cancer Epidemiology Report provides an overview of the risk factors and global trends of endometrial cancer in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and Canada).
– It also includes a 10-year epidemiology forecast of the diagnosed incident and five-year diagnosed prevalent cases of endometrial cancer in these markets from 2020-2030. The incident cases are further segmented by age, International Federation of Gynecology and Obstetrics (FIGO) stage at diagnosis (I, II, IIIA, and IV), subtype (endometrioid, clear cell, serous, carcinosarcoma, and other), and associated biomarkers: microsatellite instability (MSI) high, mismatch repair deficiency (MMR-D), polymerase ? (POLE ) ultra mutation, MSI hypermutated, copy number low (CN low), copy number high (CN high), programmed death-ligand 1 (PDL-1), and human epidermal growth factor receptor 2 (HER-2) positivity.
– The endometrial cancer epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
– The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to Buy this Report-
The Endometrial Cancer Epidemiology series will allow you to –
– Develop business strategies by understanding the trends shaping and driving the global endometrial cancer market.
– Quantify patient populations in the global endometrial cancer market to improve product design, pricing, and launch plans.
– Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for endometrial cancer therapeutics in each of the markets covered.
– Understand magnitude of endometrial cancer population by stage at diagnosis, subtypes, and mutations.

Single User License: US $ 3995
Get FLAT 25% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=4430796

Table of Contents
1 Endometrial Cancer: Executive Summary
1.1 Related Reports
1.2 Upcoming Reports
2 Epidemiology
2.1 Disease Background
2.2 Risk Factors and Comorbidities
2.3 Global and Historical Trends
2.4 Forecast Methodology
2.4.1 Sources
2.4.2 Forecast Assumptions and Methods
2.4.3 Forecast Assumptions and Methods: Diagnosed Incident Cases of Endometrial Cancer
2.4.4 Diagnosed Incident Cases of Endometrial Cancer by FIGO Stage at Diagnosis
2.4.5 Diagnosed Incident Cases of Endometrial Cancer by Subtype
2.4.6 Diagnosed Incident Cases of Endometrial Cancer by Associated Biomarker
2.4.7 Five-Year Diagnosed Prevalent Cases of Endometrial Cancer
2.5 Epidemiological Forecast for for Endometrial Cancer (2020-2030)
2.5.1 Diagnosed Incident Cases of Endometrial Cancer
2.5.2 Age-Specific Diagnosed Incident Cases of Endometrial Cancer
2.5.3 Diagnosed Incident Cases of Endometrial Cancer by FIGO Stage
2.5.4 Diagnosed Incident Cases of Endometrial Cancer by Subtype
2.5.5 Diagnosed Incident Cases of Endometrial Cancer with Associated Biomarkers
2.5.6 Diagnosed Incident Cases of Endometrial Cancer with HER2 Positivity by FIGO Stage
2.5.7 Five-Year Diagnosed Prevalent Cases of Endometrial Cancer
2.6 Discussion
2.6.1 Epidemiological Forecast Insight
2.6.2 COVID-19 Impact
2.6.3 Limitations of the Analysis
2.6.4 Strengths of the Analysis
3 Appendix
3.1 Bibliography
3.2 About the Authors
3.2.1 Epidemiologist
3.2.2 Reviewers
3.2.3 Global Director of Therapy Analysis and Epidemiology
3.2.4 Global Head and EVP of Healthcare Operations and Strategy
Contact Us

+ 1 888 391 5441
sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.